首页> 美国卫生研究院文献>Journal of Clinical Medicine >Multicenter Study of Intense Pulsed Light for Patients with Refractory Aqueous-Deficient Dry Eye Accompanied by Mild Meibomian Gland Dysfunction
【2h】

Multicenter Study of Intense Pulsed Light for Patients with Refractory Aqueous-Deficient Dry Eye Accompanied by Mild Meibomian Gland Dysfunction

机译:耐火含水性缺陷患者强烈脉冲光的多中心研究伴有轻度美联孔腺体功能障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aqueous-deficient dry eye (ADDE) and meibomian gland dysfunction (MGD) can be refractory to therapy. Intense pulsed light (IPL) was recently introduced as an effective treatment for MGD. We here evaluated the efficacy of IPL combined with MG expression (MGX) compared with MGX alone (n = 23 and 20, respectively) for patients with refractory ADDE with mild MGD at three sites. Symptom score, visual acuity (VA), noninvasive breakup time (NIBUT) and lipid layer thickness (LLT) of the tear film, lid margin abnormalities, fluorescein BUT (FBUT), fluorescein staining, tear meniscus height (TMH), meibum grade, meiboscore, and Schirmer’s test value were assessed at baseline and 1 and 3 months after treatment. LLT, plugging, vascularity, FBUT and NIBUT were improved only in the IPL-MGX group at three months compared with baseline. All parameters with the exception of VA, meiboscore, TMH, Schirmer’s test value were also improved in the IPL-MGX group compared with the control group at three months, as was VA in patients with central corneal epitheliopathy. Although IPL-MGX does not affect aqueous layer, the induced improvement in quality and quantity of the lipid layer may increase tear film stability and ameliorate symptoms not only for evaporative dry eye but for ADDE.
机译:水性缺陷的干眼液(ADDE)和Meibomian腺体功能障碍(MGD)可以难以治疗。最近将激烈的脉冲光(IPL)作为MGD的有效治疗。我们在这里评估了与仅在三个位点的耐火剂含量的耐火剂含量(分别为n = 23和20)与Mgx相比,将IPL与Mg表达(MGX)相结合的疗效。症状评分,视力(VA),非侵入性分析时间(NIBUT)和脂质层厚度(LLT)的撕裂膜,盖子缘异常,荧光素(FBUT),荧光素染色,泪缘染色体高度(TMH),梅花植物等级,梅斯科古罗路和席氏切的测试价值在基线和治疗后1和3个月内评估。与基线相比,LLT,堵塞,血管性,FBUT和NIBUT仅在IPL-MGX组中得到改善。除了在三个月的三个月内,IPL-MGX组除了VA,Meiboscore,TMH,Schirmer的试验值外,Schirmer的所有参数也得到了改善,与中央角膜上皮细胞病患者的患者是VA的。尽管IPL-MGX不影响水层,但脂质层的质量和量的诱导提高可能增加撕裂膜稳定性,并且不仅可以用于蒸发干眼,而且改善症状,而是用于加入。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号